SRNMN

Serial Number 90599907
Registration 6969727
700

Registration Progress

Application Filed
Mar 24, 2021
Under Examination
Nov 23, 2021
Approved for Publication
Sep 28, 2021
Published for Opposition
Sep 28, 2021
Registered
Jan 31, 2023

Trademark Image

SRNMN

Basic Information

Serial Number
90599907
Registration Number
6969727
Filing Date
March 24, 2021
Registration Date
January 31, 2023
Published for Opposition
September 28, 2021
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 31, 2023
Registration
Registered
Classes
001 005

Rights Holder

Seragon Pharmaceuticals Inc.

03
Address
400 Spectrum Center Dr., Ste. 1600
Irvine, CA 92618

Ownership History

Seragon Pharmaceuticals Inc.

Original Applicant
03
Irvine, CA

Seragon Pharmaceuticals Inc.

Owner at Publication
03
Irvine, CA

Seragon Pharmaceuticals Inc.

Original Registrant
03
Irvine, CA

Legal Representation

Attorney
Chris P. Cheng

USPTO Deadlines

Next Deadline
1104 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230131)
Due Date
January 31, 2029
Grace Period Ends
July 31, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

27 events
Date Code Type Description Documents
Jul 9, 2025 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Jul 9, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 9, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 9, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 31, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jan 31, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 30, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Dec 29, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Dec 29, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 29, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 28, 2022 ALIE A ASSIGNED TO LIE Loading...
Nov 2, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 3, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 3, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 3, 2022 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Apr 19, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Apr 5, 2022 IUAF S USE AMENDMENT FILED Loading...
Apr 19, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 5, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Nov 23, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 28, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 28, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 8, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 21, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 20, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 29, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 27, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Vitamins for use in the manufacture of pharmaceuticals
First Use Anywhere: Jun 4, 2021
First Use in Commerce: Jun 4, 2021
Class 005
Dietary supplements; Pharmaceutical agents affecting metabolism
First Use Anywhere: Jun 4, 2021
First Use in Commerce: Jun 4, 2021

Classification

International Classes
001 005